Lugh@futurology.todayM to Futurology@futurology.todayEnglish · 9 days agoHuidaGene Therapeutics used CRISPR gene-editing (Cas13) to modify genes in the brain for the first time, successfully treating a 9-year-old with MECP2 duplication syndrome.archive.phexternal-linkmessage-square0fedilinkarrow-up11arrow-down10
arrow-up11arrow-down1external-linkHuidaGene Therapeutics used CRISPR gene-editing (Cas13) to modify genes in the brain for the first time, successfully treating a 9-year-old with MECP2 duplication syndrome.archive.phLugh@futurology.todayM to Futurology@futurology.todayEnglish · 9 days agomessage-square0fedilink
